- By St. Teresa Medical
- Press Releases
First Patient Enrolled in SURGICLOT® Clinical Trial in U.K.
July 13, 2015 - St. Paul, MN - St. Teresa Medical, Inc. today announced the enrollment of the first patient into its human clinical trial for its product, SURGICLOT®, which is classified by the U.K.’s regulatory agency MHRA, and Nemko PreSafe, a global testing and certification company specializing in medical devices, as a medical device class 111 with medicinal ancillary action. On June 18, St. Teresa Medical received approval for a 40-patient study from MHRA in the U.K.